J Gen Virol Try Microbiology Online
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Gen Virol 71 (1990), 43-52; DOI 10.1099/0022-1317-71-1-43
© 1990 Society for General Microbiology

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pevear, D. C.
Right arrow Articles by Jubelt, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pevear, D. C.
Right arrow Articles by Jubelt, B.
Agricola
Right arrow Articles by Pevear, D. C.
Right arrow Articles by Jubelt, B.

Localization of Genomic Regions Specific for the Attenuated, Mouse-adapted Poliovirus Type 2 Strain W-2

Daniel C. Pevear{dagger}, Chad K. Oh{ddagger}>, Laura L. Cunningham, Miriam Calenoff and Burk Jubelt§

The Les Turner ALS Research Laboratory, Department of Neurology, Northwestern University Medical School, 303 E. Chicago Avenue, Chicago, Illinois 60611, U.S.A.

In order to begin to elucidate the genomic basis of the attenuation of mouse-adapted, poliovirus type 2 strain W-2 (PV2/W-2), we have cloned and sequenced the virus and compared it with the virulent, mouse-adapted PV2/Lansing strain. In addition, we have performed computer-generated comparisons of PV2/W-2 to the non-mouse-adapted, attenuated PV2/Sabin strain to determine whether mutational patterns occur that result in attenuation. The PV2/W-2 genome is 7434 nucleotides in length, which is three bases shorter than PV2/Lansing. The 5' non-coding region of PV2/W-2 is 747 nucleotides in length (compared to 744 in PV2/Lansing) and shares 98·8% identity with PV2/Lansing and 82.3% identity with PV2/Sabin. Overall, the PV2/W-2 polyprotein (2205 amino acids) is two amino acids shorter than that of either PV2/Lansing or PV2/Sabin (2207 amino acids). These contiguous deletions fall within the P3-D region (polymerase). Within these 2205 amino acid residues only 26 differences were observed between PV2/W-2 and PV2/Lansing (98·8% identity), whereas 92 occurred between PV2/W-2 and PV2/Sabin (95·8% identity). The 3' non-coding region of PV2/W-2 is 72 nucleotides in length and shares 100% identity with PV2/Lansing and 98·6% identity with PV2/Sabin. Amino acid changes in the capsid protein region occurred in neutralization sites 1 and 3, areas previously shown to be important for pathogenicity. The cleavage site between non-structural proteins P2-C/P3-A consisted of a glutamine-serine pair, in contrast to other sequenced polioviruses which have a glutamine-glycine dipeptide.

{dagger} Present address: Sterling Drug Incorporated, Rensselaer, New York, U.S.A.

{ddagger}> Present address: Department of Pediatrics, Rush-Presbyterian-St Luke's Hospital, Chicago, Illinois, U.S.A.

§ Present address: Department of Neurology, SUNY Health Science Center, 750 East Adams St, Syracuse, New York 13210, U.S.A.

Received 28 July 1989; accepted 26 September 1989.


This article has been cited by other articles:


Home page
J. Virol.Home page
M. L. Yakovenko, E. A. Cherkasova, G. V. Rezapkin, O. E. Ivanova, A. P. Ivanov, T. P. Eremeeva, O. Y. Baykova, K. M. Chumakov, and V. I. Agol
Antigenic Evolution of Vaccine-Derived Polioviruses: Changes in Individual Epitopes and Relative Stability of the Overall Immunological Properties
J. Virol., March 15, 2006; 80(6): 2641 - 2653.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
C. Adami, A. E. Pritchard, T. Knauf, M. Luo, and H. L. Lipton
A Determinant for Central Nervous System Persistence Localized in the Capsid of Theiler's Murine Encephalomyelitis Virus by Using Recombinant Viruses
J. Virol., February 1, 1998; 72(2): 1662 - 1665.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
INT J SYST EVOL MICROBIOL MICROBIOLOGY J GEN VIROL
J MED MICROBIOL ALL SGM JOURNALS
Copyright © 1990 by the Society for General Microbiology.